度普利尤单抗治疗特应性皮炎和泛发性斑秃的疗效观察

Alotaibi Lama, Alfawzan Abdulrahman, Alharthi Raghad, Al Sheikh Afaf

Division of Dermatology, Department of Medicine, Prince Sultan Military Medical City, Riyadh.

College of Medicine, King Saud University for Health Sciences, Riyadh.

Dermatol Reports. 2021 Dec 28;14(2):9359. doi: 10.4081/dr.2022.9359. eCollection 2022 Jun 16.

Dupilumab is an interleukin-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis and alopecia totalis after dupilumab treatment for AD. We present one of reported cases that showed improvement of underlying alopecia universalis treated with dupilumab.

度普利尤单抗是一种白细胞介素-4受体α拮抗剂，已显示出对特应性皮炎（AD）有显著改善作用。许多报告表明，在使用度普利尤单抗治疗AD后，斑秃、全秃和普秃有显著缓解。我们报告其中一例使用度普利尤单抗治疗后潜在普秃得到改善的病例。